Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other Non-Current Assets: 2019-2025

Historic Other Non-Current Assets for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to $19,000.

  • Eton Pharmaceuticals' Other Non-Current Assets rose 58.33% to $19,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $19,000, marking a year-over-year increase of 58.33%. This contributed to the annual value of $12,000 for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Eton Pharmaceuticals' Other Non-Current Assets stood at $19,000, which was up 58.33% from $12,000 recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Other Non-Current Assets registered a high of $36,000 during Q1 2021, and its lowest value of $12,000 during Q1 2022.
  • Over the past 3 years, Eton Pharmaceuticals' median Other Non-Current Assets value was $12,000 (recorded in 2025), while the average stood at $12,636.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first tumbled by 71.60% in 2021, then skyrocketed by 58.33% in 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Other Non-Current Assets (Quarterly) stood at $21,000 in 2021, then tumbled by 42.86% to $12,000 in 2022, then remained steady at $12,000 in 2023, then remained steady at $12,000 in 2024, then spiked by 58.33% to $19,000 in 2025.
  • Its last three reported values are $19,000 in Q3 2025, $12,000 for Q2 2025, and $12,000 during Q1 2025.